| |
| F2R; coagulation factor II (thrombin) receptor [KO: K03914] |
| |
| EGF; epidermal growth factor [KO: K04357] |
| FGF16; fibroblast growth factor 16 [KO: K04358] |
| FGF19; fibroblast growth factor 19 [KO: K04358] |
| FGF2; fibroblast growth factor 2 (basic) [KO: K04358] |
| FGF1; fibroblast growth factor 1 (acidic) [KO: K04358] |
| FGF20; fibroblast growth factor 20 [KO: K04358] |
| FGF12; fibroblast growth factor 12 [KO: K04358] |
| FGF6; fibroblast growth factor 6 [KO: K04358] |
| FGF23; fibroblast growth factor 23 [KO: K04358] |
| FGF9; fibroblast growth factor 9 (glia-activating factor) [KO: K04358] |
| FGF5; fibroblast growth factor 5 [KO: K04358] |
| FGF7; fibroblast growth factor 7 [KO: K04358] |
| FGF3; fibroblast growth factor 3 [KO: K04358] |
| FGF4; fibroblast growth factor 4 [KO: K04358] |
| FGF13; fibroblast growth factor 13 [KO: K04358] |
| FGF18; fibroblast growth factor 18 [KO: K04358] |
| FGF14; fibroblast growth factor 14 [KO: K04358] |
| FGF8; fibroblast growth factor 8 (androgen-induced) [KO: K04358] |
| FGF10; fibroblast growth factor 10 [KO: K04358] |
| fibroblast growth factor 22-like; K04358 fibroblast growth factor [KO: K04358] |
| PDGFA; platelet-derived growth factor alpha polypeptide [KO: K04359] |
| PDGFB; platelet-derived growth factor beta polypeptide [KO: K04359] |
| PDGFC; platelet derived growth factor C [KO: K05450] |
| PDGFD; platelet derived growth factor D [KO: K05450] |
| |
| |
| |
| |
| |
| PDGFRA; platelet-derived growth factor receptor, alpha polypeptide [KO: K04363] [EC: 2.7.10.1] |
| PDGFRB; platelet-derived growth factor receptor, beta polypeptide [KO: K05089] [EC: 2.7.10.1] |
| FN1; fibronectin 1 [KO: K05717] |
| ITGA1; integrin, alpha 1 [KO: K06480] |
| integrin alpha-2-like; K06481 integrin alpha 2 [KO: K06481] |
| ITGA3; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) [KO: K06482] |
| ITGA4; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) [KO: K06483] |
| ITGA6; integrin, alpha 6 [KO: K06485] |
| ITGA8; integrin, alpha 8 [KO: K06584] |
| ITGA9; integrin, alpha 9 [KO: K06585] |
| ITGA11; integrin, alpha 11 [KO: K06587] |
| ITGAV; integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) [KO: K06487] |
| ITGB1; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) [KO: K05719] |
| ITGB2; integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) [KO: K06464] |
| ITGB3; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) [KO: K06493] |
| ITGB4; integrin, beta 4 [KO: K06525] |
| ITGB5; integrin, beta 5 [KO: K06588] |
| ITGB6; integrin, beta 6 [KO: K06589] |
| ITGB8; integrin, beta 8 [KO: K06591] |
| BDKRB1; bradykinin receptor B1 [KO: K03915] |
| BDKRB2; bradykinin receptor B2 [KO: K03916] |
| CHRM2; cholinergic receptor, muscarinic 2 [KO: K04130] |
| CHRM3; cholinergic receptor, muscarinic 3 [KO: K04131] |
| CHRM4; cholinergic receptor, muscarinic 4 [KO: K04132] |
| CHRM5; cholinergic receptor, muscarinic 5 [KO: K04133] |
| GNA12; guanine nucleotide binding protein (G protein) alpha 12 [KO: K04346] |
| GNA13; guanine nucleotide binding protein (G protein), alpha 13 [KO: K04639] |
| GNG12; guanine nucleotide binding protein (G protein), gamma 12 [KO: K04347] |
| FGD3; FYVE, RhoGEF and PH domain containing 3 [KO: K05722] |
| |
| BCAR1; breast cancer anti-estrogen resistance 1 [KO: K05726] |
| CRK; v-crk sarcoma virus CT10 oncogene homolog (avian) [KO: K04438] |
| CRKL; v-crk sarcoma virus CT10 oncogene homolog (avian)-like [KO: K04438] |
| DOCK1; dedicator of cytokinesis 1 [KO: K13708] |
| |
| SOS2; son of sevenless homolog 2 (Drosophila) [KO: K03099] |
| son of sevenless homolog 1-like; K03099 son of sevenless [KO: K03099] |
| HRAS; v-Ha-ras Harvey rat sarcoma viral oncogene homolog [KO: K02833] |
| KRAS; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog [KO: K07827] |
| NRAS; neuroblastoma RAS viral (v-ras) oncogene homolog [KO: K07828] |
| RRAS2; related RAS viral (r-ras) oncogene homolog 2 [KO: K07830] |
| MRAS; muscle RAS oncogene homolog [KO: K07831] |
| ARHGEF6; Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 [KO: K05729] |
| PIK3CA; phosphoinositide-3-kinase, catalytic, alpha polypeptide [KO: K00922] [EC: 2.7.1.153] |
| PIK3CD; phosphoinositide-3-kinase, catalytic, delta polypeptide [KO: K00922] [EC: 2.7.1.153] |
| PIK3CG; phosphoinositide-3-kinase, catalytic, gamma polypeptide [KO: K00922] [EC: 2.7.1.153] |
| PIK3CB; phosphoinositide-3-kinase, catalytic, beta polypeptide [KO: K00922] [EC: 2.7.1.153] |
| PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma) [KO: K02649] |
| PIK3R5; phosphoinositide 3-kinase regulatory subunit 5 [KO: K02649] |
| PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta) [KO: K02649] |
| PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha) [KO: K02649] |
| VAV3; vav 3 guanine nucleotide exchange factor [KO: K05730] |
| VAV2; vav 2 guanine nucleotide exchange factor [KO: K05730] |
| TIAM1; T-cell lymphoma invasion and metastasis 1 [KO: K05731] |
| BRAF; v-raf murine sarcoma viral oncogene homolog B1 [KO: K04365] [EC: 2.7.11.1] |
| RAF1; v-raf-1 murine leukemia viral oncogene homolog 1 [KO: K04366] [EC: 2.7.11.1] |
| MOS; v-mos Moloney murine sarcoma viral oncogene homolog [KO: K04367] [EC: 2.7.11.1] |
| MAP2K1; mitogen-activated protein kinase kinase 1 [KO: K04368] [EC: 2.7.12.2] |
| MAP2K2; mitogen-activated protein kinase kinase 2 [KO: K04369] [EC: 2.7.12.2] |
| |
| ARHGEF12; Rho guanine nucleotide exchange factor (GEF) 12 [KO: K07532] |
| ARHGAP35; Rho GTPase activating protein 35 [KO: K05732] |
| RHOA; ras homolog gene family, member A [KO: K04513] |
| RAC1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) [KO: K04392] |
| RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) [KO: K07860] |
| RAC3; ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) [KO: K07861] |
| CDC42; cell division cycle 42 (GTP binding protein, 25kDa) [KO: K04393] |
| PAK1; p21 protein (Cdc42/Rac)-activated kinase 1 [KO: K04409] [EC: 2.7.11.1] |
| PAK2; p21 protein (Cdc42/Rac)-activated kinase 2 [KO: K04410] [EC: 2.7.11.1] |
| PAK3; p21 protein (Cdc42/Rac)-activated kinase 3 [KO: K05733] [EC: 2.7.11.1] |
| PAK4; p21 protein (Cdc42/Rac)-activated kinase 4 [KO: K05734] [EC: 2.7.11.1] |
| PAK6; p21 protein (Cdc42/Rac)-activated kinase 6 [KO: K05735] [EC: 2.7.11.1] |
| PAK7; p21 protein (Cdc42/Rac)-activated kinase 7 [KO: K05736] [EC: 2.7.11.1] |
| ARHGEF7; Rho guanine nucleotide exchange factor (GEF) 7 [KO: K13710] |
| GIT1; G protein-coupled receptor kinase interactor 1 [KO: K05737] |
| ROCK1; Rho-associated, coiled-coil containing protein kinase 1 [KO: K04514] [EC: 2.7.11.1] |
| |
| |
| |
| |
| MYLK4; myosin light chain kinase family, member 4 [KO: K00907] [EC: 2.7.11.18] |
| PPP1CB; protein phosphatase 1, catalytic subunit, beta isozyme [KO: K06269] [EC: 3.1.3.16] |
| PPP1CC; protein phosphatase 1, catalytic subunit, gamma isozyme [KO: K06269] [EC: 3.1.3.16] |
| PPP1R12A; protein phosphatase 1, regulatory (inhibitor) subunit 12A [KO: K06270] |
| PPP1R12B; protein phosphatase 1, regulatory (inhibitor) subunit 12B [KO: K12329] |
| MYL2; myosin, light chain 2, regulatory, cardiac, slow [KO: K10351] |
| MYL9; myosin, light chain 9, regulatory [KO: K12755] |
| MYL10; myosin, light chain 10, regulatory [KO: K12756] |
| MYL12A; myosin, light chain 12A, regulatory, non-sarcomeric [KO: K12757] |
| myosin regulatory light chain 2; K12757 myosin regulatory light chain 12 [KO: K12757] |
| MYLPF; myosin light chain, phosphorylatable, fast skeletal muscle [KO: K12758] |
| DIAPH1; diaphanous homolog 1 (Drosophila) [KO: K05741] |
| SLC9A1; solute carrier family 9 (sodium/hydrogen exchanger), member 1 [KO: K05742] |
| PIP5K1B; phosphatidylinositol-4-phosphate 5-kinase, type I, beta [KO: K00889] [EC: 2.7.1.68] |
| PIP5K1C; phosphatidylinositol-4-phosphate 5-kinase, type I, gamma [KO: K00889] [EC: 2.7.1.68] |
| PIP5K1A; phosphatidylinositol-4-phosphate 5-kinase, type I, alpha [KO: K00889] [EC: 2.7.1.68] |
| phosphatidylinositol-4-phosphate 5-kinase type-1 alpha-like; K00889 1-phosphatidylinositol-4-phosphate 5-kinase [EC: 2.7.1.68] [KO: K00889] [EC: 2.7.1.68] |
| PIP4K2A; phosphatidylinositol-5-phosphate 4-kinase, type II, alpha [KO: K00920] [EC: 2.7.1.149] |
| PIP4K2B; phosphatidylinositol-5-phosphate 4-kinase, type II, beta [KO: K00920] [EC: 2.7.1.149] |
| PIKFYVE; phosphoinositide kinase, FYVE finger containing [KO: K00921] [EC: 2.7.1.150] |
| |
| |
| DIAPH3; diaphanous homolog 3 (Drosophila) [KO: K05745] |
| BAIAP2; BAI1-associated protein 2 [KO: K05627] |
| ENAH; enabled homolog (Drosophila) [KO: K05746] |
| WASL; Wiskott-Aldrich syndrome-like [KO: K05747] |
| WASF2; WAS protein family, member 2 [KO: K05748] |
| CYFIP2; cytoplasmic FMR1 interacting protein 2 [KO: K05749] |
| CYFIP1; cytoplasmic FMR1 interacting protein 1 [KO: K05749] |
| NCKAP1; NCK-associated protein 1 [KO: K05750] |
| NCKAP1L; NCK-associated protein 1-like [KO: K05750] |
| ABI2; abl-interactor 2 [KO: K05751] |
| WASF1; WAS protein family, member 1 [KO: K05753] |
| ARPC5; actin related protein 2/3 complex, subunit 5, 16kDa [KO: K05754] |
| ARPC4; actin related protein 2/3 complex, subunit 4, 20kDa [KO: K05755] |
| ARPC3; actin related protein 2/3 complex, subunit 3, 21kDa [KO: K05756] |
| ARPC1B; actin related protein 2/3 complex, subunit 1B, 41kDa [KO: K05757] |
| ARPC1A; actin related protein 2/3 complex, subunit 1A, 41kDa [KO: K05757] |
| ARPC2; actin related protein 2/3 complex, subunit 2, 34kDa [KO: K05758] |
| |
| ACTRT1; actin-related protein T1 [KO: K05692] |
| ACTG1; actin, gamma 1 [KO: K05692] |
| actin; K05692 actin beta/gamma 1 [KO: K05692] |
| |
| PFN4; profilin family, member 4 [KO: K05759] |
| |
| |
| |
| |
| TMSB4X; thymosin beta 4, X-linked [KO: K05764] |
| CFL2; cofilin 2 (muscle) [KO: K05765] |
| SSH2; slingshot homolog 2 (Drosophila) [KO: K05766] |
| |
| IQGAP1; IQ motif containing GTPase activating protein 1 [KO: K16848] |
| |
| |
| ACTN1; actinin, alpha 1 [KO: K05699] |
| ACTN4; actinin, alpha 4 [KO: K05699] |
| ACTN2; actinin, alpha 2 [KO: K05699] |
| APC; adenomatous polyposis coli [KO: K02085] |
| APC2; adenomatosis polyposis coli 2 [KO: K02085] |
| ARHGEF4; Rho guanine nucleotide exchange factor (GEF) 4 [KO: K05769] |
